Huntington National Bank’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-21
Closed -$6.84K 4171
2024
Q1
$6.84K Buy
21
+5
+31% +$1.23K ﹤0.01% 1824
2023
Q4
$3.05K Sell
16
-30
-65% -$5.67K ﹤0.01% 1998
2023
Q3
$9.16K Sell
46
-12
-21% -$2.84K ﹤0.01% 1591
2023
Q2
$16.6K Sell
58
-108
-65% -$30K ﹤0.01% 1424
2023
Q1
$36K Buy
166
+32
+24% +$6.24K ﹤0.01% 1114
2022
Q4
$27.6K Buy
134
+10
+8% +$2.53K ﹤0.01% 1181
2022
Q3
$34K Sell
124
-30
-19% -$7.63K ﹤0.01% 1111
2022
Q2
$29K Hold
154
﹤0.01% 1201
2022
Q1
$32K Buy
154
+23
+18% +$3.79K ﹤0.01% 1216
2021
Q4
$23K Buy
+131
New +$25.8K ﹤0.01% 1338

Other funds holding SWAV

Huntington National Bank's SWAV Position: Q2 2024 in Review

Huntington National Bank sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 21 shares — an estimated $6.84K sold.

Huntington National Bank first reported a position in SWAV in Q4 2021 and held it in 10 quarters. The position peaked at $36K in Q1 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Huntington National Bank reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Huntington National Bank sold 21 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $6.84K.
  • Huntington National Bank first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2021 and held it in 10 quarters.
  • Huntington National Bank's Shockwave Medical, Inc. Common Stock position peaked at $36K in Q1 2023.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Huntington National Bank's 13F filing for Q2 2024, filed 8 Aug 2024.